Bacterial vaccines for fish
- 31 December 1993
- journal article
- Published by Elsevier BV in Annual Review of Fish Diseases
- Vol. 3, 145-185
- https://doi.org/10.1016/0959-8030(93)90033-8
Abstract
Vaccination of fish for the prevention of specific bacterial diseases afffecting commercially reared fish species has had a significant impact on this industry. Almost all of the vaccines available at this time are bacterins or formalin-inactivated whole cell suspensions, some with adjuvants. The first vaccines to be successfully commercialized were those against Vibrio anguillarum, Vibrio ordalii , and Yersinia ruckeri in the late 1970s. Developed initially for the salmonid industry, these bacterins are now routinely used worldwide on many species of fish. Though in some areas salmon farming has flourished without the use of these vaccines, in most areas they have been essential to the economic viability of aquaculture operations. Vaccines against Vibrio salmonicida , a pathogen of salmonids, Aeromonas salmonicida , a pathogen of salmonids and carp, and Edwardsiella ictaluri , a pathogen of channel catfish have also been commercialized and are in widespread use. A number of other bacterins have been the subject of research and some of them may eventually be available. Though a bacterin against Vibrio parahaemolyticus , a pathogen affecting species of fish reared in warmwater has been successfully tested, as have bacterins against Aeromonas hydrophila and Edwardsiella tarda , the serologic heterogeneity of these groups of organisms make it unlikely that widely utilizable vaccines will be available in the near future. Those pathogens that appear to be serologically more homogeneous, including Flexibacter columnaris, Pasteurella piscicida and Streptococcus species affecting fish, will likely end up in commercially available bacterins in the not too distant future. The use of a new generation of adjuvants in conjunction with automated injection methods could result in vaccines that will protect against diseases that conventional methods may not be successful against, such as bacterial kidney disease (BKD) caused by Renibacterium salmoninarum .Keywords
This publication has 170 references indexed in Scilit:
- Vaccination of Atlantic salmon (Salmo salar L.) against cold-water vibriosis — duration of protection and effect on growth rateAquaculture, 1991
- A field trial of vaccination against cold-water vibriosis in Atlantic salmon (Salmo salar L.)Aquaculture, 1990
- Protective immunity in juvenile coho salmon Oncorhynchus kisutch following immunization with Vibrio ordalii lipopolysaccharide or from exposure to live V. ordalii cellsDiseases of Aquatic Organisms, 1990
- A cost-effectiveness study of three different methods of vaccination against vibriosis in salmonidsAquaculture, 1989
- Vaccination against Vibrio salmonicida The effect of different routes of administration and of revaccinationAquaculture, 1989
- Principal microbial diseases of mariculture in JapanAquaculture, 1987
- The quantitative relationship between vaccine dilution, length of immersion time and antigen uptake, using a radiolabelled Aeromonas salmonicida bath in direct immersion experiments with rainbow trout, Salmo gairdneriAquaculture, 1987
- Ecology ofVibriospecies, includingVibrio cholerae, in natural waters of Kent, EnglandJournal of Applied Bacteriology, 1982
- The immune system of cyprinid fish. The immunosuppressive effect of the antibiotic oxytetracycline in carp (Cyprinus carpio L.)Aquaculture, 1980
- Survival and growth of vaccinated, medicated and untreated coho salmon (Oncorhynchus kisutch) exposed to Vibrio anguillarumAquaculture, 1977